Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Effect of subthalamic nucleus stimulation during exercise on the mesolimbocortical dopaminergic region in Parkinson's disease: a positron emission tomography study.

Nozaki T, Sugiyama K, Yagi S, Yoshikawa E, Kanno T, Asakawa T, Ito T, Terada T, Namba H, Ouchi Y.

J Cereb Blood Flow Metab. 2013 Mar;33(3):415-21. doi: 10.1038/jcbfm.2012.183. Epub 2012 Dec 5.

2.

Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.

Nimura T, Yamaguchi K, Ando T, Shibuya S, Oikawa T, Nakagawa A, Shirane R, Itoh M, Tominaga T.

J Neurosurg. 2005 Dec;103(6):968-73.

PMID:
16381182
3.

Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release.

Abosch A, Kapur S, Lang AE, Hussey D, Sime E, Miyasaki J, Houle S, Lozano AM.

Neurosurgery. 2003 Nov;53(5):1095-102; discussion 1102-5.

PMID:
14580276
4.

Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans.

Hilker R, Voges J, Ghaemi M, Lehrke R, Rudolf J, Koulousakis A, Herholz K, Wienhard K, Sturm V, Heiss WD.

Mov Disord. 2003 Jan;18(1):41-8.

PMID:
12518299
5.

Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.

Thobois S, Fraix V, Savasta M, Costes N, Pollak P, Mertens P, Koudsie A, Le Bars D, Benabid AL, Broussolle E.

J Neurol. 2003 Oct;250(10):1219-23.

PMID:
14586606
6.

Endogenous dopamine release induced by repetitive transcranial magnetic stimulation over the primary motor cortex: an [11C]raclopride positron emission tomography study in anesthetized macaque monkeys.

Ohnishi T, Hayashi T, Okabe S, Nonaka I, Matsuda H, Iida H, Imabayashi E, Watabe H, Miyake Y, Ogawa M, Teramoto N, Ohta Y, Ejima N, Sawada T, Ugawa Y.

Biol Psychiatry. 2004 Mar 1;55(5):484-9.

PMID:
15023576
7.

Effect of simple motor performance on regional dopamine release in the striatum in Parkinson disease patients and healthy subjects: a positron emission tomography study.

Ouchi Y, Yoshikawa E, Futatsubashi M, Okada H, Torizuka T, Sakamoto M.

J Cereb Blood Flow Metab. 2002 Jun;22(6):746-52.

8.

In vivo mesolimbic D2/3 receptor binding predicts posttherapeutic clinical responses in restless legs syndrome: a positron emission tomography study.

Oboshi Y, Ouchi Y, Yagi S, Kono S, Nakai N, Yoshikawa E, Futatsubashi M, Terada T, Kim K, Harada K.

J Cereb Blood Flow Metab. 2012 Apr;32(4):654-62. doi: 10.1038/jcbfm.2011.201. Epub 2012 Jan 11.

9.

Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study.

Thobois S, Vingerhoets F, Fraix V, Xie-Brustolin J, Mollion H, Costes N, Mertens P, Benabid AL, Pollak P, Broussolle E.

Arch Neurol. 2004 Nov;61(11):1705-9.

PMID:
15534182
10.
11.

Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.

During MJ, Kaplitt MG, Stern MB, Eidelberg D.

Hum Gene Ther. 2001 Aug 10;12(12):1589-91.

PMID:
11529246
12.

Frequency-correlated decreases of motor cortex activity associated with subthalamic nucleus stimulation in Parkinson's disease.

Haslinger B, Kalteis K, Boecker H, Alesch F, Ceballos-Baumann AO.

Neuroimage. 2005 Nov 15;28(3):598-606. Epub 2005 Aug 2.

PMID:
16081302
13.

Improved sensory gating of urinary bladder afferents in Parkinson's disease following subthalamic stimulation.

Herzog J, Weiss PH, Assmus A, Wefer B, Seif C, Braun PM, Pinsker MO, Herzog H, Volkmann J, Deuschl G, Fink GR.

Brain. 2008 Jan;131(Pt 1):132-45. Epub 2007 Oct 30.

14.

Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.

Tedroff J, Pedersen M, Aquilonius SM, Hartvig P, Jacobsson G, Långström B.

Neurology. 1996 May;46(5):1430-6.

PMID:
8628494
15.

Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.

Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D, Pierantozzi M, Brusa L, Scarnati E, Mazzone P.

Brain. 2007 Jun;130(Pt 6):1596-607. Epub 2007 Jan 24.

16.

Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease.

Eusebio A, Witjas T, Cohen J, Fluchère F, Jouve E, Régis J, Azulay JP.

J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):868-74. doi: 10.1136/jnnp-2012-302387. Epub 2013 Feb 27.

PMID:
23447648
17.

Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease.

Weinberger M, Mahant N, Hutchison WD, Lozano AM, Moro E, Hodaie M, Lang AE, Dostrovsky JO.

J Neurophysiol. 2006 Dec;96(6):3248-56. Epub 2006 Sep 27.

18.

Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson's disease.

Herzog J, Weiss PH, Assmus A, Wefer B, Seif C, Braun PM, Herzog H, Volkmann J, Deuschl G, Fink GR.

Brain. 2006 Dec;129(Pt 12):3366-75. Epub 2006 Oct 31.

19.

Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation.

Hilker R, Portman AT, Voges J, Staal MJ, Burghaus L, van Laar T, Koulousakis A, Maguire RP, Pruim J, de Jong BM, Herholz K, Sturm V, Heiss WD, Leenders KL.

J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1217-21.

20.

Effects of subthalamic nucleus stimulation on striatal dopaminergic transmission in patients with Parkinson's disease within one-year follow-up.

Hesse S, Strecker K, Winkler D, Luthardt J, Scherfler C, Reupert A, Oehlwein C, Barthel H, Schneider JP, Wegner F, Meyer P, Meixensberger J, Sabri O, Schwarz J.

J Neurol. 2008 Jul;255(7):1059-66. doi: 10.1007/s00415-008-0849-z. Epub 2008 May 2.

PMID:
18446306
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk